Futura Medical Share Discussion Threads

[5oletrader] 17/7/2019 08:50

Stuffing Your Faces at the Trough Little Piggies? Be Fearful when Others are Greedy? FUM Up 780%+ Since beginning of Year - But... its going to the Moon, Right!?!! Phase 3 European Efficacy Study - estimated completion - end of Q4 2019 Phase 3 European Efficacy Study - Open Label EXTENSION - estimated completion - end of Q3 2020 Phase 3 SECOND (2nd) Efficacy Study - estimated completion end of Q4 2020 EARLIEST Regulatory Submission for EU Q2 2020 - US? Who knows? Don't forget another fund raise along the way. Just saying! P.S - BARDER is in Charge - he is a man that gets things done! ;-)

[qs99] 17/7/2019 08:16

well a nice blue opening anyway, GLA

[qs99] 17/7/2019 08:12

more to come today?

[j777j] 17/7/2019 07:48

I guess Zak Mir is looking at the energy of the rise in august 2016 when the shares moved from 20p to 90p in around one month. This time around we are 3 months away from phase 3 trials results. Charts are not gospel but can provide useful information about likely moves. 2016 was likely a dress rehearsal,now comes the main event.

[tommyl1] 17/7/2019 04:26

I was actually thinking leaks of a different type....good one though

[glavey] 17/7/2019 03:58

Ahh, you've heard about the incontinence side effect then.

[tommyl1] 16/7/2019 19:42

Great couple of days. Maybe some leaks from study participants as to how well it works? That would be nice.

[brucie5] 16/7/2019 18:54

Well, he's a chartist, so to be taken with a pinch of salt. But many would have bought here because, effectively, it is going up, and 'every share price tells a story'. It should not be the only factor, clearly.

[ragnarr] 16/7/2019 18:52

Everyone has some capability, influence and credibility - its just a matter of how much :-)

[bg23] 16/7/2019 17:46

I'm not being funny, but Zak Mir has no investment capability, influence or credibility. he's been unsuccessfully self promoting for over 20 years. don't think he has any insight, because he doesn't !

[ny boy] 16/7/2019 16:36

I was buying these in the Spring when I was chilling in Morocco around 15p from memory, see no reason to sell, holding for 2-5 yrs.

[qs99] 16/7/2019 16:19

Does look very strong buying, each time it gets sold down, up it goes again. Let's see what unfolds, but last 3 weeks right angled increase and doubling of share price suggests something worthwhile IMO! DYOR

[goldie40] 16/7/2019 16:18

big buyer moping all these sells looks like stake building for take over

[j777j] 16/7/2019 15:05

Zak Mir has just upped one month target for futura to 80p. GLA

[wantage] 16/7/2019 14:18

Perhaps the chart will let me knowLombards next move. Now that would be something!

[ih_116147] 16/7/2019 13:40

You like FUM ? Then you will love Diurnal Group (DNL.L) a brutally undervalued & undiscovered gem . Diurnal has a ridiculous low valuation of only £24 Million and over £11 million in cash , the company has already one Drug (Alkindi)approved in europe since last year ,NDA submission for US approval expected next quarter . They have another Drug called Chronocort for which they expect to submit the MAA to EMA for European approval by next quarter .Get some and enjoy the ride to 100p++ very soon thank me later Diurnal Group (DNL.L) Market Cap £25 Million Cash £11.5 Million Price 27p hxxps://www.diurnal.co.uk/non-healthcare-professionals/media/news/placing-open-offer-and-notice-of-general-meeting/ oFiling a Market Authorisation Application (MAA) for Chronocort® in Europe by end 2019; oFiling a New Drug Application (NDA) for Alkindi® in the US by end 2019; oContinuing the development of the European commercial organisation and roll-out of Alkindi® in Europe to maximise revenues; and oProgressing licensing discussions for Alkindi® and Chronocort® in the US and the rest of the world Martin Whitaker, PhD, Chief Executive Officer of Diurnal, commented: “Diurnal has continued to make strong progress across its business, including the successful launch of Alkindi® in Europe and confirmation of the regulatory paths for Chronocort® in Europe and Alkindi® in the US, where regulatory submissions are planned for Q4 2019. The funds raised will allow us to progress our vision of becoming a world-leading specialty pharma company in endocrinology, in particular to support the commercial infrastructure for the further roll-out of Alkindi® in Europe, paving the way for the expected future launch of Chronocort®, and to secure partnerships for Alkindi® and Chronocort® outside of Europe.”

[guessing] 16/7/2019 13:06

According to Zak Mir at Share Talk FUM is set to hit 80p in the next month or two hxxps://www.share-talk.com/share-talk-bulletin-board-heroes-tuesday-16th-july-2019/

[j777j] 16/7/2019 12:15

60p next resistance.

[wantage] 16/7/2019 12:09

Lombard Odier selling into strengthAs they always do when there's enough buying interest.in this case we are hostages to fortune.No disclosures on buy side, wonder if Liberum has got institutions nibbling.Would be wonderful to see someone Buying chunk of L O's stake if they'd Let it go.I'm waiting for next rns announcingAnother million share reduction, and price coming back a few pence.50p hard to crack.

[j777j] 16/7/2019 11:52

If you take a very conservative look at the numbers,Liberum's 140p is in my opinion a low end valuation range of 140p/250p if trials are passed with flying colours.

[kop202] 16/7/2019 11:27

It's up in 5 -10minutes......but how long does it stay up?Some women can be very demanding

[j777j] 16/7/2019 11:15

The question must be whether any potential licensee decides it is better to conclude a deal at these levels? If not, pay possibly vast amounts more,in a bidding war with other players. The product is first major ED breakthrough in 20 years. Is applied topically Works within 5 to 10 mins v up to one hour for Viagra,Cialis etc. Please form an orderly queue.

[tiananmen] 16/7/2019 10:59

But why wait till Sept/Dec when the writing is on the wall now about the potential